I am still very on the fence on this since the Adcom. I hope we all make money when the decision arrives
MarkyBoy212
semana passada
A new buy rating and 2 maintained buys very nice
A new buy rating and 2 maintained buys very nice, hoping this gets approval after earnings and award
ByronKS
semana passada
Capricor earnings report
See the Capricor Therapeutics earnings report below. Good luck! 🤞🏼🍀
https://web.quartr.com/link/companies/5913/events/732825/report?rp=0&documentId=4012432
MarkyBoy212
há 2 semanas
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
Capricor’s HOPE-3 Phase 3 Cardiac Results for Deramiocel Win American Heart Association Outstanding Research Award in Pediatric Cardiology
TerraNova23
há 2 semanas
Anyone else think this will fail?
According to Adam Feuerstein, Capricor faces two major risks:
Weak Clinical Evidence: The FDA may consider Deramiocel's efficacy data insufficient for approval.
Public Pressure on the FDA: Capricor's public statements could suggest concerns about its chances of approval.
And there is still the 3-9 vote from before.
Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress
Prayers
há 3 meses
This too (and yh I DO wish I did this in CFD lol)
GGGGM
há 3 meses
Thank God for this stock today
$CAPR to the rescue, thank you thus far... NFA
kosen
há 3 meses
This pattern looks exactly like yesterday.
If it completely duplicates yesterday’s pattern, we see 11.5 Today???
kosen
há 3 meses
What do we think
At a loss now, watching a bit
GGGGM
há 3 meses
We going up.. The News is here.. NFA.
$CAPR would soar today as the long awaited news is finally here.
The FDA accepted a major amendment to Capricor's Biologics License Application (BLA) containing 24-month Phase 3 HOPE-3 extension data. Instead of issuing an immediate rejection, the FDA extended the PDUFA target action date to November 22, 2026.
I got in early at $8 and waiting to see above 11 and above..
Note that THIS IS NOT A FINANCIAL ADVICE... NFA
SKM2086
há 3 meses
PT - $54
I'm going with a conservative $25-30. We're on the right track now. Definitely close to making permanent moves upwards.
https://uk.investing.com/news/stock-market-news/oppenheimer-upgrades-capricor-stock-rating-on-regulatory-update-93CH-4846076
MarkyBoy212
há 3 meses
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA nice news guys
Hazlaw1234
há 3 meses
$CAPR feels like one to watch very closely today 👀
The official PDUFA target date is tomorrow, Saturday 22 August, but with that falling on a weekend there’s a very real possibility we hear something from the FDA today instead.
As of now there’s been no decision announced, so I’d expect a lot of eyes on CAPR once the US session gets going and especially into after hours.
Could be a very important day for the stock. Definitely worth keeping notifications on.
NFA
Esta página pode conter conteúdos gerados pela comunidade pelos quais a Trading 212 não é responsável. Faz sempre a tua própria pesquisa. A Trading 212 presta um serviço apenas de execução e não oferece aconselhamento de investimento ou gestão de portefólios.
Investe automaticamente com as Pies: o teu plano de investimento regular e flexível
Investe em Pies pré-definidas ou cria a tua, escolhendo entre milhares de ações e ETFs
Saber mais
Saber mais
Ver o vídeo
Mesmo as ações com preço mais elevado ficam ao teu alcance. Compra apenas uma fração de empresas como a Alphabet (Google), a Amazon ou a Apple.
Ver o vídeo
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Bolsa de Valores de Londres
Euronext Lisboa
Euronext Paris
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Bolsa de Valores de Londres
Euronext Lisboa
Ver todos os Instrumentos
Suporte 24/7
Tempo de resposta médio de 29 segundos
Começa a investir hoje
Junta-te a mais de 5 milhões de clientes
Obter a aplicação
Abrir conta
Descarrega a aplicação
Os dados apresentados são globais e referem-se a todas as entidades do grupo Trading 212. O número indicado corresponde ao total de clientes que abriram e financiaram pelo menos uma conta desde a fundação da empresa, excluindo os clientes cujas contas tenham sido encerradas ou desativadas.
Excelente
Classificação de 4,6 / 5 com base nos 108.764 comentários em
Trustpilot
Classificação de 4,6 / 5 com base nos 108.764 comentários em
Trustpilot
Convidado
Great app very easy to use and lots of…
Great app very easy to use and lots of information. Always upto date with balances and share prices etc.
Convidado
Smooth experience
The whole thing is smooth and seamless and makes things easy overall.
Convidado
Really easy to use
Really easy to use. Secure and has the best functionality and features.
Convidado
Easy to keep up with as informed…
Easy to keep up with as informed everyday or week on interest made . Easy to set up account . No problems .
Convidado
Easy to operate and work with
Easy to operate and work with. Works very fast and accurately.
Convidado
How you rate the app
This app is so easy to use and safe really love it.
Convidado
I opened a cash ISA with them
I opened a cash ISA with them. It was really straightforward to do and interest is added daily. Nice ,easy to use app as well.
Convidado
Easy to navigate makes investing…
Easy to navigate makes investing interesting, transferred my investments from HL which was very straightforward and now not paying dealing fee’s
Very Happy
Convidado
App is easy to work
App is easy to work
Good interest rate
Daily interest updates
Convidado
Very good and informative always stay…
Very good and informative always stay on track with your investments
Convidado
Reliable
Reliable, trustworthy app to store your money and to build on your existing wealth if you are financially sensible and smart.
Convidado
Great app
Great app. I would recommend to anyone that’s into investing and making their money grow .
Convidado
Very easy app to register and use
Very easy app to register and use! Really pleased.
Convidado
Clear app
Clear app. Easy to invest. Took a whike for money to get in because i did it from bank rather than in app
Convidado
Very smooth and user friendly
Very smooth and user friendly. Have had zero issues having moved from other brokerages. Will keep using.
Convidado
Easy to set up and to regular monitor…
Easy to set up and to regular monitor how its performing.
Convidado
Competitive rates and quick transfers
Very good on money transfers in and out. They take place immediately unlike some other providers.
Very competitive rate on Cash ISA
Convidado
Customer support is quick and…
Customer support is quick and effective. The app is well organised and easy to use. Would reccommend for anyone even complete beginners.
Convidado
Easy to set up the Cash ISA
Easy to set up the Cash ISA, funds arrived in account almost immediately. Great to see interest accrual amounts daily.
Convidado
Reliable
Reliable, Secure. Using it for past 3 years
Apresentamos algumas das avaliações positivas dos nossos clientes
Os nossos prémios
Perguntas frequentes
Qual é o preço da ação Capricor Therapeutics?
O preço atual de Capricor Therapeutics é $ 7,59.
Qual é a máxima de 52 semanas de Capricor Therapeutics?
A máxima de 52 semanas para Capricor Therapeutics é $ 40,37.
Qual é a mínima de 52 semanas de Capricor Therapeutics?
A mínima de 52 semanas de Capricor Therapeutics é $ 2,96.
Qual é o desempenho semanal de Capricor Therapeutics?
Na última semana, o preço de Capricor Therapeutics mudou em -20,36%.
Qual é o desempenho mensal de Capricor Therapeutics?
No último mês, o preço de Capricor Therapeutics mudou em 14,14%.
Qual é o desempenho em 3 meses de Capricor Therapeutics?
Nos últimos três meses, o preço de Capricor Therapeutics mudou em -4,89%.
Qual é o desempenho de 6 meses de Capricor Therapeutics?
Nos últimos seis meses, o preço de Capricor Therapeutics mudou em -71,81%.
Qual é o desempenho anual de Capricor Therapeutics?
No último ano, o preço de Capricor Therapeutics mudou em 31,54%.